JP2011527678A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011527678A5 JP2011527678A5 JP2011517467A JP2011517467A JP2011527678A5 JP 2011527678 A5 JP2011527678 A5 JP 2011527678A5 JP 2011517467 A JP2011517467 A JP 2011517467A JP 2011517467 A JP2011517467 A JP 2011517467A JP 2011527678 A5 JP2011527678 A5 JP 2011527678A5
- Authority
- JP
- Japan
- Prior art keywords
- coch
- compound
- structural formula
- independently
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(OC(CC(O)OC1*)C1O)=O Chemical compound CC(OC(CC(O)OC1*)C1O)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7996808P | 2008-07-11 | 2008-07-11 | |
| US61/079,968 | 2008-07-11 | ||
| PCT/US2009/048675 WO2010005799A2 (en) | 2008-07-11 | 2009-06-25 | Novel acetates of 2-deoxy monosaccharides with anticancer activity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015000024A Division JP5890043B2 (ja) | 2008-07-11 | 2015-01-05 | 抗癌活性を有する２−デオキシ単糖の新規なアセテート |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011527678A JP2011527678A (ja) | 2011-11-04 |
| JP2011527678A5 true JP2011527678A5 (enExample) | 2012-08-09 |
| JP5677951B2 JP5677951B2 (ja) | 2015-02-25 |
Family
ID=41507670
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011517467A Expired - Fee Related JP5677951B2 (ja) | 2008-07-11 | 2009-06-25 | 抗癌活性を有する２−デオキシ単糖の新規なアセテート |
| JP2015000024A Expired - Fee Related JP5890043B2 (ja) | 2008-07-11 | 2015-01-05 | 抗癌活性を有する２−デオキシ単糖の新規なアセテート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015000024A Expired - Fee Related JP5890043B2 (ja) | 2008-07-11 | 2015-01-05 | 抗癌活性を有する２−デオキシ単糖の新規なアセテート |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8927506B2 (enExample) |
| EP (1) | EP2310020B1 (enExample) |
| JP (2) | JP5677951B2 (enExample) |
| CN (1) | CN102149388B (enExample) |
| DK (1) | DK2310020T3 (enExample) |
| ES (1) | ES2628180T3 (enExample) |
| HU (1) | HUE033210T2 (enExample) |
| LT (1) | LT2310020T (enExample) |
| PL (1) | PL2310020T3 (enExample) |
| WO (1) | WO2010005799A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9149489B2 (en) | 2006-04-27 | 2015-10-06 | Board Of Regents, University Of Texas System | Inhibitors of glycolysis useful in the treatment of brain tumors |
| US8927506B2 (en) | 2008-07-11 | 2015-01-06 | Board Of Regents, The University Of Texas System | Acetates of 2-deoxy monosaccharides with anticancer activity |
| WO2012097052A2 (en) * | 2011-01-11 | 2012-07-19 | Intertech Bio, Llc | Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases |
| WO2012142615A2 (en) * | 2011-04-14 | 2012-10-18 | Board Of Regents, The University Of Texas System | Auranofin and auranofin analogs useful to treat proliferative disease and disorders |
| CN104470543A (zh) * | 2012-04-12 | 2015-03-25 | 国立大学法人岐阜大学 | 梗塞治疗用医药组合物 |
| ES2897699T3 (es) | 2013-04-05 | 2022-03-02 | Univ Texas | Esteres de 2-desoxi-monosacáridos con actividad antiproliferativa |
| WO2020035782A1 (en) * | 2018-08-13 | 2020-02-20 | Dermin Sp. Z O.O. | Molecular probes for analysis of metabolism of glycolysis inhibitors prodrugs and synthesis methods therefore |
| IL296389A (en) | 2020-03-16 | 2022-11-01 | Univ Texas | Method of treating viral infections with hexose type monosaccharides and analogs thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56103197A (en) * | 1980-01-21 | 1981-08-18 | Wakamoto Pharmaceut Co Ltd | Novel d-glucose derivative and antitumor agent containing the same as active constitutent |
| JPS58167582A (ja) | 1982-03-29 | 1983-10-03 | Takeda Chem Ind Ltd | 糖ケタ−ルの製造法 |
| US6319695B1 (en) | 1991-10-15 | 2001-11-20 | The Scripps Research Insitute | Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose |
| CN1196059A (zh) * | 1995-06-23 | 1998-10-14 | 牛津糖科学(英国)有限公司 | 治疗化合物 |
| EE200200565A (et) | 2000-03-31 | 2004-06-15 | Angiogene Pharmaceuticals Ltd. | Vaskulaarse kahjustava toimega kombinatsioonravi |
| US6670330B1 (en) | 2000-05-01 | 2003-12-30 | Theodore J. Lampidis | Cancer chemotherapy with 2-deoxy-D-glucose |
| CN1541106A (zh) | 2001-06-11 | 2004-10-27 | 转新疗法公司 | 用维生素b12和治疗剂联合治疗病毒性、增殖性和炎性疾病的方法 |
| WO2003018598A2 (en) | 2001-08-30 | 2003-03-06 | University College Dublin | Monosaccharide derivatives |
| WO2003082301A1 (en) | 2002-03-29 | 2003-10-09 | Threshold Pharmaceuticals, Inc. | Compositions and methods for treating cancer |
| AU2004204778B2 (en) * | 2003-01-10 | 2008-05-22 | Threshold Pharmaceuticals, Inc. | Treatment of cancer with 2-deoxyglucose |
| CA2431425A1 (en) | 2003-06-05 | 2004-12-05 | Angiogene, Inc. | Epas1 gene transfer to improve cell therapy |
| WO2005065721A2 (en) | 2003-12-30 | 2005-07-21 | Board Of Regents, The University Of Texas System | Use of an anti-inflammatory compound for the reduction of inflammation secondary to the administration of a lipid-nucleic acid complex |
| WO2006024488A2 (en) | 2004-08-30 | 2006-03-09 | Interstitial Therapeutics | Medical stent provided with inhibitors of atp synthesis |
| CN101426508A (zh) | 2006-02-24 | 2009-05-06 | 得克萨斯系统大学评议会 | 治疗癌症的己糖化合物 |
| EP1986660A4 (en) | 2006-02-24 | 2009-08-26 | Univ Texas | HEXOSE COMPOUNDS FOR CANCER TREATMENT |
| US9149489B2 (en) | 2006-04-27 | 2015-10-06 | Board Of Regents, University Of Texas System | Inhibitors of glycolysis useful in the treatment of brain tumors |
| EP1881000A1 (en) * | 2006-07-17 | 2008-01-23 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Conjugates of 2-fluoro-2-deoxy-glucose and their uses as anti cancer agents |
| WO2008131024A1 (en) | 2007-04-17 | 2008-10-30 | Board Of Regents, The University Of Texas System | Iodo-hexose compounds useful to treat cancer |
| US8927506B2 (en) | 2008-07-11 | 2015-01-06 | Board Of Regents, The University Of Texas System | Acetates of 2-deoxy monosaccharides with anticancer activity |
| WO2012142615A2 (en) | 2011-04-14 | 2012-10-18 | Board Of Regents, The University Of Texas System | Auranofin and auranofin analogs useful to treat proliferative disease and disorders |
-
2009
- 2009-06-25 US US13/003,429 patent/US8927506B2/en active Active
- 2009-06-25 LT LTEP09794965.5T patent/LT2310020T/lt unknown
- 2009-06-25 JP JP2011517467A patent/JP5677951B2/ja not_active Expired - Fee Related
- 2009-06-25 HU HUE09794965A patent/HUE033210T2/hu unknown
- 2009-06-25 WO PCT/US2009/048675 patent/WO2010005799A2/en not_active Ceased
- 2009-06-25 CN CN200980135924.XA patent/CN102149388B/zh not_active Expired - Fee Related
- 2009-06-25 PL PL09794965T patent/PL2310020T3/pl unknown
- 2009-06-25 ES ES09794965.5T patent/ES2628180T3/es active Active
- 2009-06-25 DK DK09794965.5T patent/DK2310020T3/en active
- 2009-06-25 EP EP09794965.5A patent/EP2310020B1/en active Active
-
2015
- 2015-01-05 JP JP2015000024A patent/JP5890043B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009502743A5 (enExample) | ||
| JP2014500861A5 (enExample) | ||
| JP2013523733A5 (enExample) | ||
| JP2010519260A5 (enExample) | ||
| JP2013518107A5 (enExample) | ||
| JP2013509429A5 (enExample) | ||
| JP2012144574A5 (enExample) | ||
| JP2008543854A5 (enExample) | ||
| JP2017518302A5 (enExample) | ||
| UY30809A1 (es) | Derivados de n-[3-[4-fenil)piperidin-1-carbonil]fenil]sulfonamidas sustituidas, procesos de preparacion y aplicaciones | |
| JP2010525056A5 (enExample) | ||
| JP2011518833A5 (enExample) | ||
| JP2016515561A5 (enExample) | ||
| JP2010001302A5 (enExample) | ||
| JP2013525444A5 (enExample) | ||
| JP2013534248A5 (enExample) | ||
| JP2017505785A5 (enExample) | ||
| JP2012506872A5 (enExample) | ||
| JP2007302689A5 (enExample) | ||
| JP2013522326A5 (enExample) | ||
| JP2011527299A5 (enExample) | ||
| JP2012509265A5 (enExample) | ||
| JP2011046708A5 (enExample) | ||
| EP2090577A8 (en) | Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors | |
| JP2008536853A5 (enExample) |